• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌梗死患者中miR-542-3p表达的变化及其诊断意义

Changes and Diagnostic Significance of miR-542-3p Expression in Patients with Myocardial Infarction.

作者信息

Chen Yu, Liu Shuke, Zhang Xueshan, Zuo Changpeng

机构信息

Department of Cardiology, Wuxi Xishan People's Hospital, Wuxi, 214000, China.

Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.

出版信息

Mol Biotechnol. 2024 Sep 6. doi: 10.1007/s12033-024-01272-w.

DOI:10.1007/s12033-024-01272-w
PMID:39242489
Abstract

Acute myocardial infarction (AMI) is a heart lesion, that endangers the life safety of patients. This study focused on exploring the clinical effect of miR-542-3p on AMI and no-reflow after percutaneous coronary intervention (PCI). Serum samples were collected from 100 AMI emergency inpatients. The expression of miR-542-3p was quantified by qPCR. The predictive role of miR-542-3p was disclosed by plotting ROC curve. In addition, AMI subjects were cataloged into a group of no-reflow and normal reflow group. The risk factors of no-reflow were estimated by logistic regression analysis. In the serum samples of AMI patients, the level of miR-542-3p showed a pattern of decreasing. MiR-542-3p expression represented a high sensitivity and specificity of the prediction of AMI. A decrease of miR-542-3p content was revealed in AMI patients without reflow after PCI. Logistic regression results reflected that miR-542-3p was an independent biomarker for no-reflow. The declined miR-542-3p expression was a predictive marker for AMI and no-reflow in AMI patients.

摘要

急性心肌梗死(AMI)是一种危及患者生命安全的心脏病变。本研究聚焦于探讨miR-542-3p对急性心肌梗死及经皮冠状动脉介入治疗(PCI)后无复流的临床影响。收集了100例急性心肌梗死急诊住院患者的血清样本。通过qPCR对miR-542-3p的表达进行定量。绘制ROC曲线揭示miR-542-3p的预测作用。此外,将急性心肌梗死患者分为无复流组和正常复流组。通过逻辑回归分析评估无复流的危险因素。在急性心肌梗死患者的血清样本中,miR-542-3p水平呈下降趋势。miR-542-3p表达对急性心肌梗死的预测具有较高的敏感性和特异性。PCI后无复流的急性心肌梗死患者中miR-542-3p含量降低。逻辑回归结果表明,miR-542-3p是无复流的独立生物标志物。miR-542-3p表达下降是急性心肌梗死患者急性心肌梗死及无复流的预测标志物。

相似文献

1
Changes and Diagnostic Significance of miR-542-3p Expression in Patients with Myocardial Infarction.心肌梗死患者中miR-542-3p表达的变化及其诊断意义
Mol Biotechnol. 2024 Sep 6. doi: 10.1007/s12033-024-01272-w.
2
PCSK-9 Inhibitors Can Significantly Improve the Coronary Slow Flow Caused by Elevated Lipoprotein (a) in ST-Elevation Myocardial Infarction Patients With Chronic Kidney Disease.前蛋白转化酶枯草溶菌素9(PCSK-9)抑制剂可显著改善慢性肾脏病合并ST段抬高型心肌梗死患者因脂蛋白(a)升高所致的冠状动脉慢血流现象。
Catheter Cardiovasc Interv. 2025 Jul;106(1):396-407. doi: 10.1002/ccd.31543. Epub 2025 Apr 25.
3
Effect of dapagliflozin on the no-reflow phenomenon in patients with acute myocardial infarction and type II diabetes mellitus.达格列净对急性心肌梗死合并2型糖尿病患者无复流现象的影响。
Acta Cardiol. 2025 Jun;80(4):394-402. doi: 10.1080/00015385.2025.2500892. Epub 2025 May 14.
4
Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.急性心肌梗死患者在直接经皮冠状动脉介入治疗期间使用腺苷和维拉帕米治疗无复流现象。
Cochrane Database Syst Rev. 2015 May 18;2015(5):CD009503. doi: 10.1002/14651858.CD009503.pub3.
5
Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.急性心肌梗死患者在直接经皮冠状动脉介入治疗期间使用腺苷和维拉帕米治疗无复流现象。
Cochrane Database Syst Rev. 2013 Jun 4(6):CD009503. doi: 10.1002/14651858.CD009503.pub2.
6
Study on the mechanism and clinical value of miR-210-3p and miR-582-5p in acute myocardial infarction by targeting MXD1.靶向MXD1的miR-210-3p和miR-582-5p在急性心肌梗死中的作用机制及临床价值研究
J Cardiothorac Surg. 2025 Jul 4;20(1):282. doi: 10.1186/s13019-025-03518-3.
7
Construct a nomogram prediction and evaluation of influencing factors of adverse pregnancy outcomes in GDM patients based on plasma miR-144-3p levels.基于血浆miR-144-3p水平构建预测妊娠期糖尿病(GDM)患者不良妊娠结局的列线图并评估影响因素。
Front Endocrinol (Lausanne). 2025 Jun 23;16:1548780. doi: 10.3389/fendo.2025.1548780. eCollection 2025.
8
Combined prediction value of coronary plaque burden, serum creatinine, MLR and NLR in reinfarction risk after PCI in middle-aged and elderly patients with myocardial infarction.心肌梗死中老年患者PCI术后再梗死风险中冠状动脉斑块负荷、血清肌酐、单核细胞与淋巴细胞比值及中性粒细胞与淋巴细胞比值的联合预测价值
Eur J Med Res. 2025 Jun 24;30(1):522. doi: 10.1186/s40001-025-02804-z.
9
Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.冠状动脉内给药对ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗期间无复流现象的影响:一项网状Meta分析。
BMC Cardiovasc Disord. 2018 Jan 10;18(1):3. doi: 10.1186/s12872-017-0722-z.
10
Clinical value of serum miR-214-3p expression in the diagnosis of type 2 diabetes mellitus and prediction of its chronic complications.血清miR-214-3p表达在2型糖尿病诊断及慢性并发症预测中的临床价值
BMC Endocr Disord. 2025 Apr 14;25(1):98. doi: 10.1186/s12902-025-01916-1.

引用本文的文献

1
Advances in Pathophysiology and Novel Therapeutic Strategies for Coronary No-Reflow Phenomenon.冠状动脉无复流现象的病理生理学进展及新型治疗策略
Biomedicines. 2025 Jul 14;13(7):1716. doi: 10.3390/biomedicines13071716.
2
AhR Activation at the Air-Blood Barrier Alters Systemic microRNA Release After Inhalation of Particulate Matter Containing Environmentally Persistent Free Radicals.空气-血液屏障处的芳烃受体激活改变了吸入含有环境持久性自由基的颗粒物后全身微小RNA的释放。
Cardiovasc Toxicol. 2025 May;25(5):651-665. doi: 10.1007/s12012-025-09989-z. Epub 2025 Apr 11.

本文引用的文献

1
Isoflurane pretreatment protects against myocardial ischemia/reperfusion injury via mediating lncRNA CASC15/miR-542-3p axis.异氟醚预处理通过介导 lncRNA CASC15/miR-542-3p 轴保护心肌缺血/再灌注损伤。
Toxicol Mech Methods. 2024 Jul;34(6):694-702. doi: 10.1080/15376516.2024.2327057. Epub 2024 Apr 4.
2
Effect of CASC15 on apoptosis and oxidative stress of cardiomyocytes after hypoxia/reperfusion injury.CASC15 对缺氧/再灌注损伤后心肌细胞凋亡及氧化应激的影响。
Rev Port Cardiol. 2024 Feb;43(2):77-84. doi: 10.1016/j.repc.2023.04.017. Epub 2023 Aug 29.
3
A Nomogram model for predicting the occurrence of no-reflow phenomenon after percutaneous coronary intervention using the lncRNA /miR-30e/ biomarkers.
一种使用lncRNA/miR-30e/生物标志物预测经皮冠状动脉介入治疗后无复流现象发生的列线图模型。
J Thorac Dis. 2022 Jun;14(6):2158-2168. doi: 10.21037/jtd-22-481.
4
Research Progress on the Relationship Between Inflammation and Colorectal Cancer.炎症与结直肠癌关系的研究进展
Ann Gastroenterol Surg. 2021 Nov 10;6(2):204-211. doi: 10.1002/ags3.12517. eCollection 2022 Mar.
5
Post-traumatic Stress Disorder and Risk Factors in Patients With Acute Myocardial Infarction After Emergency Percutaneous Coronary Intervention: A Longitudinal Study.急诊经皮冠状动脉介入治疗后急性心肌梗死患者的创伤后应激障碍及其危险因素:一项纵向研究
Front Psychol. 2021 Dec 14;12:694974. doi: 10.3389/fpsyg.2021.694974. eCollection 2021.
6
miR-190-5p Alleviates Myocardial Ischemia-Reperfusion Injury by Targeting PHLPP1.miR-190-5p 通过靶向 PHLLP1 减轻心肌缺血再灌注损伤。
Dis Markers. 2021 Nov 25;2021:8709298. doi: 10.1155/2021/8709298. eCollection 2021.
7
Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association.急性心肌梗死的机械并发症:美国心脏协会的科学声明。
Circulation. 2021 Jul 13;144(2):e16-e35. doi: 10.1161/CIR.0000000000000985. Epub 2021 Jun 15.
8
Tetrandrine Ameliorates Myocardial Ischemia Reperfusion Injury through miR-202-5p/TRPV2.粉防己碱通过 miR-202-5p/TRPV2 减轻心肌缺血再灌注损伤。
Biomed Res Int. 2021 Mar 8;2021:8870674. doi: 10.1155/2021/8870674. eCollection 2021.
9
Bivalirudin in patients undergoing percutaneous coronary intervention and independent predictors of postoperative adverse events in these patients: A real world retrospective study.比伐卢定在经皮冠状动脉介入治疗患者中的应用及这些患者术后不良事件的独立预测因素:一项真实世界回顾性研究。
Medicine (Baltimore). 2021 Mar 12;100(10):e25003. doi: 10.1097/MD.0000000000025003.
10
A nomogram for predicting the risk of no-reflow after primary percutaneous coronary intervention in elderly patients with ST-segment elevation myocardial infarction.用于预测老年ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后无复流风险的列线图。
Ann Transl Med. 2021 Jan;9(2):126. doi: 10.21037/atm-20-8003.